Add to ORKGquinolone; ofloxacin; and sparfloxacin against In vitro activities of OPC-17116, a ne
The in vitro activities of three new quinolones (sparfloxacin, CI-960, and PD 131,628) were compared...
Sparfloxacin, a difluorquinolone derivative, is a potent antibacterial agent active against a wide r...
The activity of the fluoroquinolone olamufloxacin (HSR-903) against Legionella spp. was studied in v...
The in vitro and in vivo activities of three newly developed quinolone antimicrobial agents (sparflo...
The in vivo antichlamydial activities of sparfloxacin and reference drugs were examined in a experim...
Sparfloxacin was found to display a biphask response against Escherichia coli, Staphylococcus aureus...
Sparfloxacin is a new antimicrobial that, while maintaining a good activity against gram negative ba...
In vitro activities of LB20304a were compared with those of grepafloxacin (OPC-17116), Q-35, ciprofl...
The increasing emergence of penicillin-resistant and multiresistant strains of Streptococcus pneumon...
In vitro sparfloxacin was highly active against 223 penicillin-susceptible isolates of Neisseria gon...
activities of ofloxacin and ciprofloxacin. Mycobacterium tuberculosis compared with quinolone sparfl...
The in vitro susceptibilities of 10 strains of Chlamydia pneumoniae to a new 8-methoxyquinolone, BAY...
bactericidal activity against pneumococci. Pharmacokinetics of sparfloxacin and seru
The in vitro activity of OPC-17116 was compared to that of rive similar fluoroquinolones (ciprofloxa...
The in-vitro activity of Bay y 3118, a new quinolone antimicrobial was compared with that of ciprofl...
The in vitro activities of three new quinolones (sparfloxacin, CI-960, and PD 131,628) were compared...
Sparfloxacin, a difluorquinolone derivative, is a potent antibacterial agent active against a wide r...
The activity of the fluoroquinolone olamufloxacin (HSR-903) against Legionella spp. was studied in v...
The in vitro and in vivo activities of three newly developed quinolone antimicrobial agents (sparflo...
The in vivo antichlamydial activities of sparfloxacin and reference drugs were examined in a experim...
Sparfloxacin was found to display a biphask response against Escherichia coli, Staphylococcus aureus...
Sparfloxacin is a new antimicrobial that, while maintaining a good activity against gram negative ba...
In vitro activities of LB20304a were compared with those of grepafloxacin (OPC-17116), Q-35, ciprofl...
The increasing emergence of penicillin-resistant and multiresistant strains of Streptococcus pneumon...
In vitro sparfloxacin was highly active against 223 penicillin-susceptible isolates of Neisseria gon...
activities of ofloxacin and ciprofloxacin. Mycobacterium tuberculosis compared with quinolone sparfl...
The in vitro susceptibilities of 10 strains of Chlamydia pneumoniae to a new 8-methoxyquinolone, BAY...
bactericidal activity against pneumococci. Pharmacokinetics of sparfloxacin and seru
The in vitro activity of OPC-17116 was compared to that of rive similar fluoroquinolones (ciprofloxa...
The in-vitro activity of Bay y 3118, a new quinolone antimicrobial was compared with that of ciprofl...
The in vitro activities of three new quinolones (sparfloxacin, CI-960, and PD 131,628) were compared...
Sparfloxacin, a difluorquinolone derivative, is a potent antibacterial agent active against a wide r...
The activity of the fluoroquinolone olamufloxacin (HSR-903) against Legionella spp. was studied in v...